Drug profile · INN
dolutegravir sodium
DOLUTEGRAVIR SODIUM
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dolutegravir sodium (DOLUTEGRAVIR SODIUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dolutegravir sodium
Brand DOLUTEGRAVIR SODIUM
Route ORAL
Formulation TABLET, FOR SUSPENSION
Frequently asked questions
What is dolutegravir sodium?
dolutegravir sodium (DOLUTEGRAVIR SODIUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dolutegravir sodium?
DOLUTEGRAVIR SODIUM is a marketed brand name for dolutegravir sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dolutegravir sodium?
dolutegravir sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.